Ursula Schneider

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Integrative plasma-to-spatial proteomics reveals fibroblast-associated signatures in liver metastatic breast cancer.

Integrative plasma-to-spatial proteomics reveals fibroblast-associated signatures in liver metastatic breast cancer.

Journal: Cancer cell international

Published: October 09, 2025

Selective genetic inactivation of Caspase 8 in hepatocytes ameliorates progression of MASH following Jnk deficiency.

Selective genetic inactivation of Caspase 8 in hepatocytes ameliorates progression of MASH following Jnk deficiency.

Journal: Hepatology (Baltimore, Md.)

Published: November 22, 2024

Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer.

Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: November 12, 2021

Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer.

Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: November 13, 2020

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 17, 2019

Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder.

Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder.

Journal: The American journal of pathology

Published: June 28, 2019

ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?

ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?

Journal: PloS one

Published: May 07, 2018

Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications.

Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications.

Journal: Virchows Archiv : an international journal of pathology

Published: January 11, 2018

Notch inhibition counteracts Paneth cell death in absence of caspase-8.

Notch inhibition counteracts Paneth cell death in absence of caspase-8.

Journal: Virchows Archiv : an international journal of pathology

Published: June 30, 2017

Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.

Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.

Journal: Pathology, research and practice

Published: June 02, 2016

Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients.

Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients.

Journal: Molecular and clinical oncology

Published: March 13, 2015

Intestinal genetic inactivation of caspase-8 diminishes migration of enterocytes.

Intestinal genetic inactivation of caspase-8 diminishes migration of enterocytes.

Journal: World journal of gastroenterology

Published: October 15, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026